PDEX NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Pro-Dex Inc · Healthcare · Medical Instruments & Supplies

Open interactive chart View report data
Latest close 58.57 USD
6.6% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 12.2% above the Trend Line and sits at 77.1% of its 52-week range. The latest completed week returned 6.6%, after a -4.5% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 54/100. Near-term considerations: earnings are due in 24d.

Setup score 56 out of 100
Latest Close 58.57 USD 31 Jul 2026
1W Return 6.6% latest completed week
4W Return -4.5% short-term follow-through
12W Return -1.2% quarterly tape
Trend Breadth 50.0% 26 of 52 weeks active
Volume Ratio 1.1x vs 13-week average
What is working
  • The trend backdrop is active with a 23-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Activity pressure is negative, which weakens the current setup.
  • 13 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 6.6% Latest completed week; four-week move -4.5%. Indicator stack 72/40 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 54/100 30 relevant articles in the latest sentiment read. Event risk 24d Next report is scheduled for 25 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 12.2% above the Trend Line and sits at 77.1% of its 52-week range. The latest completed week returned 6.6%, after a -4.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8912-week average 0.96

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.89Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers1313 reversal markers

No recent accumulation markers. 13 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -4.5% over four weeks, -1.2% over 12 weeks, and 23.7% over one year. The current trend has remained active for 23 consecutive weeks.

Performance by holding period

1W6.6%
4W-4.5%
12W-1.2%
26W49.3%
52W23.7%
Active trend streak23 weeks
Active weeks in one year26
Trend breadth50.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.08Latest activity-pressure read.
Pressure change-105.0%Four-week change in activity pressure.
Leadership18.46Latest relative-leadership reading.
RS change-6.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength56/100Blend of value, momentum, and quality. Underlying universe rank 45; rank 1 is best.
Value35/100Relative valuation strength. Underlying universe rank 66; rank 1 is best.
Quality71/100Profitability and accounting quality. Underlying universe rank 30; rank 1 is best.
Momentum67/100Medium-term price momentum. Underlying universe rank 34; rank 1 is best.
Growth80/100Revenue and earnings growth. Underlying universe rank 21; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework78/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
14.6x
Price divided by trailing earnings.
Price / sales
2.3x
Market value relative to trailing revenue.
EV / EBITDA
9.5x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
4.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
27.8%
Gross profit retained from each unit of revenue.
Operating margin
23.2%
Operating profit retained from revenue.
Free-cash-flow margin
10.3%
Free cash flow generated from revenue.
Return on invested capital
23.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
16.4%
Latest one-year revenue growth.
EPS growth
28.1%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
900.6%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
1.6%
Net share repurchases relative to market value.
Shareholder yield
1.6%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.5x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity4 / 9

4 acquisitions and 9 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment54/100

Weighted news tone is neutral across 30 relevant articles.

12 positive · 14 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings24dNext report is scheduled for 25 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-15.1%Distance below the 52-week high.
13-week volatility7.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher16 of 269 weeks finished lower.
Best week+22.6%Week of 8 May.
Worst week-8.8%Week of 17 Jul.
Latest week+6.6%Week of 31 Jul.

Shape of recent returns

Strong gains7
Modest gains9
Flat weeks1
Modest losses4
Sharp losses5
Recent vol7.5%13-week weekly-return volatility.
Base vol8.7%52-week weekly-return volatility.
Up/down split32/19Count of positive and negative weeks in the 52-week window.
Average skew5.7% / -7.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape60/100

Trend, activity pressure, participation, and risk combine to a 60/100 tape read.

 Indicator analysis80/100

Latest 12-week confirmation: trend 12/12, activity pressure 11/12, relative leadership 12/12.

Activity pressure 0.89; 13 reversal markers Factors56/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 26; Small Cap Core rank 72 SVQF78/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 157.0 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment54/100

Weighted news tone is neutral across 30 relevant articles.

Pro-Dex Inc (PDEX) Technical Analysis: Support, Resistance, Indicators & Moving Averages Insiders4 / 9

4 acquisitions and 9 disposals in the latest 180-day insider tape.

 Earnings24d

Next report is scheduled for 25 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202658.57 USD6.6%52.22 USD34.90 USD-0.0818.46387.5KOn
24 Jul 202654.93 USD-4.3%51.52 USD34.64 USD0.2211.69486.1KOn
17 Jul 202657.38 USD-8.8%51.01 USD34.40 USD0.7214.58542.6KOn
10 Jul 202662.89 USD2.5%50.38 USD34.15 USD1.2520.36608.2KOn
3 Jul 202661.33 USD-0.2%49.73 USD33.87 USD1.5419.67259.2KOn
26 Jun 202661.47 USD-4.5%49.03 USD33.59 USD1.9520.97488.8KOn
19 Jun 202664.37 USD3.5%48.20 USD33.32 USD2.1621.13344.0KOn
12 Jun 202662.20 USD-4.6%47.14 USD33.03 USD2.2820.49360.1KOn
5 Jun 202665.21 USD0.7%46.13 USD32.75 USD2.3429.61279.6KOn
29 May 202664.77 USD2.0%44.99 USD32.46 USD2.2923.31175.5KOn
22 May 202663.52 USD7.2%44.04 USD32.17 USD2.0124.78221.6KOn
15 May 202659.27 USD0.0%42.87 USD31.88 USD1.8817.76135.0KOn
8 May 202659.27 USD22.6%41.77 USD31.61 USD1.8317.40129.2KOn
1 May 202648.36 USD-7.2%40.90 USD31.33 USD1.820.85125.9KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.